ArticleProstate cancer and prostatic diseases2024

Real-world overall survival with abiraterone acetate versus enzalutamide in chemotherapy-naïve patients with metastatic castration-resistant prostate cancer.

Daniel J George et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.